APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IV Administration Primary Set

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global IV Administration Primary Set Market Outlook and Growth Opportunities 2026

Report ID 17442580054 July 2026202 pages

Choose your research edition.

Industry ResearchIV Administration Primary Set Industry Research Report 2026136 pages · $2,950 USDIndustry Growth & TrendsGlobal IV Administration Primary Set Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal IV Administration Primary Set Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IV Administration Primary Set Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal IV Administration Primary Set Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global IV Administration Primary Set market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IV Administration Primary Set is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the IV Administration Primary Set market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the IV Administration Primary Set market include BD, SB Kawasumi, Amsino, Bayer, Baxter International, Zyno Medical, Smiths Medical, MPS Medical and Medtec Medical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IV Administration Primary Set market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IV Administration Primary Set and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IV Administration Primary Set sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IV Administration Primary Set market size, projected growth trends, production technologies, key applications, and end-use industries.

IV Administration Primary Set Segment by Company

BD

SB Kawasumi

Amsino

Bayer

Baxter International

Zyno Medical

Smiths Medical

MPS Medical

Medtec Medical

MedSource Labs

ICU Medical

Eitan Group

CODAN US Corporation

B. Braun

Advanced Medical Systems

3M

IV Administration Primary Set Segment by Type

1 - 200 Micron

More Than 200 Micron

Less Than 1 Micron

IV Administration Primary Set Segment by Application

Hospitals

Clinics

Other

IV Administration Primary Set Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global IV Administration Primary Set status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions IV Administration Primary Set market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify IV Administration Primary Set significant trends, drivers, influence factors in global and regions.

6. To analyze IV Administration Primary Set competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IV Administration Primary Set market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IV Administration Primary Set and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IV Administration Primary Set.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IV Administration Primary Set market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global IV Administration Primary Set industry.

Chapter 3: Detailed analysis of IV Administration Primary Set manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of IV Administration Primary Set in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of IV Administration Primary Set in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. IV Administration Primary Set Industry Trends Table 2. IV Administration Primary Set Industry Drivers Table 3. IV Administration Primary Set Industry Opportunities and Challenges Table 4. IV Administration Primary Set Industry Restraints Table 5. Global IV Administration Primary Set Revenue by Company (US$ Million) & (2021-2026) Table 6. Global IV Administration Primary Set Revenue Share by Company (2021-2026) Table 7. Global IV Administration Primary Set Sales Volume by Company (k units) & (2021-2026) Table 8. Global IV Administration Primary Set Sales Volume Share by Company (2021-2026) Table 9. Global IV Administration Primary Set Average Price (USD/unit) of Company (2021-2026) Table 10. Global IV Administration Primary Set Company Ranking, (2024-2026) & (USD Million) Table 11. Global IV Administration Primary Set Key Company Manufacturing Base & Headquarters Table 12. Global IV Administration Primary Set Company, Product Type & Application Table 13. Global IV Administration Primary Set Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global IV Administration Primary Set by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 1 - 200 Micron Table 18. Significant Companies of More Than 200 Micron Table 19. Significant Companies of Less Than 1 Micron Table 20. Global IV Administration Primary Set Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global IV Administration Primary Set Sales Volume by Type (2021-2026) & (k units) Table 22. Global IV Administration Primary Set Sales Volume by Type (2027-2032) & (k units) Table 23. Global IV Administration Primary Set Sales Volume Share by Type (2021-2026) Table 24. Global IV Administration Primary Set Sales Volume Share by Type (2027-2032) Table 25. Global IV Administration Primary Set Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global IV Administration Primary Set Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global IV Administration Primary Set Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global IV Administration Primary Set Sales Value Share by Type (2021-2026) Table 29. Global IV Administration Primary Set Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Hospitals Table 31. Significant Companies of Clinics Table 32. Significant Companies of Other Table 33. Global IV Administration Primary Set Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global IV Administration Primary Set Sales Volume by Application (2021-2026) & (k units) Table 35. Global IV Administration Primary Set Sales Volume by Application (2027-2032) & (k units) Table 36. Global IV Administration Primary Set Sales Volume Share by Application (2021-2026) Table 37. Global IV Administration Primary Set Sales Volume Share by Application (2027-2032) Table 38. Global IV Administration Primary Set Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global IV Administration Primary Set Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global IV Administration Primary Set Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global IV Administration Primary Set Sales Value Share by Application (2021-2026) Table 42. Global IV Administration Primary Set Sales Value Share by Application (2027-2032) Table 43. Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global IV Administration Primary Set Sales by Region (2021-2026) & (k units) Table 45. Global IV Administration Primary Set Sales Market Share by Region (2021-2026) Table 46. Global IV Administration Primary Set Sales by Region (2027-2032) & (k units) Table 47. Global IV Administration Primary Set Sales Market Share by Region (2027-2032) Table 48. Global IV Administration Primary Set Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global IV Administration Primary Set Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global IV Administration Primary Set Sales Value Share by Region (2021-2026) Table 51. Global IV Administration Primary Set Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global IV Administration Primary Set Sales Value Share by Region (2027-2032) Table 53. Global IV Administration Primary Set Market Average Price (USD/unit) by Region (2021-2026) Table 54. Global IV Administration Primary Set Market Average Price (USD/unit) by Region (2027-2032) Table 55. Global IV Administration Primary Set Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 56. Global IV Administration Primary Set Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global IV Administration Primary Set Sales by Country (2021-2026) & (k units) Table 58. Global IV Administration Primary Set Sales Market Share by Country (2021-2026) Table 59. Global IV Administration Primary Set Sales by Country (2027-2032) & (k units) Table 60. Global IV Administration Primary Set Sales Market Share by Country (2027-2032) Table 61. Global IV Administration Primary Set Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global IV Administration Primary Set Sales Value Market Share by Country (2021-2026) Table 63. Global IV Administration Primary Set Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global IV Administration Primary Set Sales Value Market Share by Country (2027-2032) Table 65. BD Company Information Table 66. BD Business Overview Table 67. BD IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 68. BD IV Administration Primary Set Product Portfolio Table 69. BD Recent Development Table 70. SB Kawasumi Company Information Table 71. SB Kawasumi Business Overview Table 72. SB Kawasumi IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 73. SB Kawasumi IV Administration Primary Set Product Portfolio Table 74. SB Kawasumi Recent Development Table 75. Amsino Company Information Table 76. Amsino Business Overview Table 77. Amsino IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 78. Amsino IV Administration Primary Set Product Portfolio Table 79. Amsino Recent Development Table 80. Bayer Company Information Table 81. Bayer Business Overview Table 82. Bayer IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 83. Bayer IV Administration Primary Set Product Portfolio Table 84. Bayer Recent Development Table 85. Baxter International Company Information Table 86. Baxter International Business Overview Table 87. Baxter International IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 88. Baxter International IV Administration Primary Set Product Portfolio Table 89. Baxter International Recent Development Table 90. Zyno Medical Company Information Table 91. Zyno Medical Business Overview Table 92. Zyno Medical IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. Zyno Medical IV Administration Primary Set Product Portfolio Table 94. Zyno Medical Recent Development Table 95. Smiths Medical Company Information Table 96. Smiths Medical Business Overview Table 97. Smiths Medical IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. Smiths Medical IV Administration Primary Set Product Portfolio Table 99. Smiths Medical Recent Development Table 100. MPS Medical Company Information Table 101. MPS Medical Business Overview Table 102. MPS Medical IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. MPS Medical IV Administration Primary Set Product Portfolio Table 104. MPS Medical Recent Development Table 105. Medtec Medical Company Information Table 106. Medtec Medical Business Overview Table 107. Medtec Medical IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. Medtec Medical IV Administration Primary Set Product Portfolio Table 109. Medtec Medical Recent Development Table 110. MedSource Labs Company Information Table 111. MedSource Labs Business Overview Table 112. MedSource Labs IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. MedSource Labs IV Administration Primary Set Product Portfolio Table 114. MedSource Labs Recent Development Table 115. ICU Medical Company Information Table 116. ICU Medical Business Overview Table 117. ICU Medical IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. ICU Medical IV Administration Primary Set Product Portfolio Table 119. ICU Medical Recent Development Table 120. Eitan Group Company Information Table 121. Eitan Group Business Overview Table 122. Eitan Group IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. Eitan Group IV Administration Primary Set Product Portfolio Table 124. Eitan Group Recent Development Table 125. CODAN US Corporation Company Information Table 126. CODAN US Corporation Business Overview Table 127. CODAN US Corporation IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 128. CODAN US Corporation IV Administration Primary Set Product Portfolio Table 129. CODAN US Corporation Recent Development Table 130. B. Braun Company Information Table 131. B. Braun Business Overview Table 132. B. Braun IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 133. B. Braun IV Administration Primary Set Product Portfolio Table 134. B. Braun Recent Development Table 135. Advanced Medical Systems Company Information Table 136. Advanced Medical Systems Business Overview Table 137. Advanced Medical Systems IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 138. Advanced Medical Systems IV Administration Primary Set Product Portfolio Table 139. Advanced Medical Systems Recent Development Table 140. 3M Company Information Table 141. 3M Business Overview Table 142. 3M IV Administration Primary Set Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 143. 3M IV Administration Primary Set Product Portfolio Table 144. 3M Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. IV Administration Primary Set Distributors List Table 148. IV Administration Primary Set Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. IV Administration Primary Set Product Image Figure 2. Global IV Administration Primary Set Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IV Administration Primary Set Sales Value (2021-2032) & (US$ Million) Figure 4. Global IV Administration Primary Set Sales (2021-2032) & (k units) Figure 5. Global IV Administration Primary Set Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global IV Administration Primary Set Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 1 - 200 Micron Image Figure 10. More Than 200 Micron Image Figure 11. Less Than 1 Micron Image Figure 12. Global IV Administration Primary Set Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global IV Administration Primary Set Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global IV Administration Primary Set Sales Volume Share by Type (2021-2032) Figure 15. Global IV Administration Primary Set Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global IV Administration Primary Set Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global IV Administration Primary Set Sales Value Share by Type (2021-2032) Figure 18. Hospitals Image Figure 19. Clinics Image Figure 20. Other Image Figure 21. Global IV Administration Primary Set Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global IV Administration Primary Set Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global IV Administration Primary Set Sales Volume Share by Application (2021-2032) Figure 24. Global IV Administration Primary Set Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global IV Administration Primary Set Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global IV Administration Primary Set Sales Value Share by Application (2021-2032) Figure 27. Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 28. Global IV Administration Primary Set Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global IV Administration Primary Set Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global IV Administration Primary Set Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America IV Administration Primary Set Sales Value (2021-2032) & (US$ Million) Figure 32. North America IV Administration Primary Set Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe IV Administration Primary Set Sales Value (2021-2032) & (US$ Million) Figure 34. Europe IV Administration Primary Set Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific IV Administration Primary Set Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific IV Administration Primary Set Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America IV Administration Primary Set Sales Value (2021-2032) & (US$ Million) Figure 38. South America IV Administration Primary Set Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa IV Administration Primary Set Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa IV Administration Primary Set Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt IV Administration Primary Set Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. IV Administration Primary Set Value Chain Figure 126. Manufacturing Cost Structure Figure 127. IV Administration Primary Set Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 1 - 200 Micron
  • More Than 200 Micron
  • Less Than 1 Micron
Applications
  • Hospitals
  • Clinics
  • Other
Companies covered
  • BD
  • SB Kawasumi
  • Amsino
  • Bayer
  • Baxter International
  • Zyno Medical
  • Smiths Medical
  • MPS Medical
  • Medtec Medical
  • MedSource Labs
  • ICU Medical
  • Eitan Group
  • CODAN US Corporation
  • B. Braun
  • Advanced Medical Systems
  • 3M

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global IV Administration Primary Set Sales Value (2021-2032)
  4. 1.2.2 Global IV Administration Primary Set Sales Volume (2021-2032)
  5. 1.2.3 Global IV Administration Primary Set Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 IV Administration Primary Set Market Dynamics
  1. 2.1 IV Administration Primary Set Industry Trends
  2. 2.2 IV Administration Primary Set Industry Drivers
  3. 2.3 IV Administration Primary Set Industry Opportunities and Challenges
  4. 2.4 IV Administration Primary Set Industry Restraints
3 IV Administration Primary Set Market by Company
  1. 3.1 Global IV Administration Primary Set Company Revenue Ranking in 2025
  2. 3.2 Global IV Administration Primary Set Revenue by Company (2021-2026)
  3. 3.3 Global IV Administration Primary Set Sales Volume by Company (2021-2026)
  4. 3.4 Global IV Administration Primary Set Average Price by Company (2021-2026)
  5. 3.5 Global IV Administration Primary Set Company Ranking (2024-2026)
  6. 3.6 Global IV Administration Primary Set Company Manufacturing Base and Headquarters
  7. 3.7 Global IV Administration Primary Set Company Product Type and Application
  8. 3.8 Global IV Administration Primary Set Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global IV Administration Primary Set Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 IV Administration Primary Set Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 IV Administration Primary Set Market by Type
  1. 4.1 IV Administration Primary Set Type Introduction
  2. 4.1.1 1 - 200 Micron
  3. 4.1.2 More Than 200 Micron
  4. 4.1.3 Less Than 1 Micron
  5. 4.2 Global IV Administration Primary Set Sales Volume by Type
  6. 4.2.1 Global IV Administration Primary Set Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global IV Administration Primary Set Sales Volume by Type (2021-2032)
  8. 4.2.3 Global IV Administration Primary Set Sales Volume Share by Type (2021-2032)
  9. 4.3 Global IV Administration Primary Set Sales Value by Type
  10. 4.3.1 Global IV Administration Primary Set Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global IV Administration Primary Set Sales Value by Type (2021-2032)
  12. 4.3.3 Global IV Administration Primary Set Sales Value Share by Type (2021-2032)
5 IV Administration Primary Set Market by Application
  1. 5.1 IV Administration Primary Set Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Other
  5. 5.2 Global IV Administration Primary Set Sales Volume by Application
  6. 5.2.1 Global IV Administration Primary Set Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IV Administration Primary Set Sales Volume by Application (2021-2032)
  8. 5.2.3 Global IV Administration Primary Set Sales Volume Share by Application (2021-2032)
  9. 5.3 Global IV Administration Primary Set Sales Value by Application
  10. 5.3.1 Global IV Administration Primary Set Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global IV Administration Primary Set Sales Value by Application (2021-2032)
  12. 5.3.3 Global IV Administration Primary Set Sales Value Share by Application (2021-2032)
6 IV Administration Primary Set Regional Sales and Value Analysis
  1. 6.1 Global IV Administration Primary Set Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IV Administration Primary Set Sales by Region (2021-2032)
  3. 6.2.1 Global IV Administration Primary Set Sales by Region: 2021-2026
  4. 6.2.2 Global IV Administration Primary Set Sales by Region (2027-2032)
  5. 6.3 Global IV Administration Primary Set Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global IV Administration Primary Set Sales Value by Region (2021-2032)
  7. 6.4.1 Global IV Administration Primary Set Sales Value by Region: 2021-2026
  8. 6.4.2 Global IV Administration Primary Set Sales Value by Region (2027-2032)
  9. 6.5 Global IV Administration Primary Set Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America IV Administration Primary Set Sales Value (2021-2032)
  12. 6.6.2 North America IV Administration Primary Set Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe IV Administration Primary Set Sales Value (2021-2032)
  15. 6.7.2 Europe IV Administration Primary Set Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific IV Administration Primary Set Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific IV Administration Primary Set Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America IV Administration Primary Set Sales Value (2021-2032)
  21. 6.9.2 South America IV Administration Primary Set Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa IV Administration Primary Set Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa IV Administration Primary Set Sales Value Share by Country, 2025 VS 2032
7 IV Administration Primary Set Country-level Sales and Value Analysis
  1. 7.1 Global IV Administration Primary Set Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global IV Administration Primary Set Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global IV Administration Primary Set Sales by Country (2021-2032)
  4. 7.3.1 Global IV Administration Primary Set Sales by Country (2021-2026)
  5. 7.3.2 Global IV Administration Primary Set Sales by Country (2027-2032)
  6. 7.4 Global IV Administration Primary Set Sales Value by Country (2021-2032)
  7. 7.4.1 Global IV Administration Primary Set Sales Value by Country (2021-2026)
  8. 7.4.2 Global IV Administration Primary Set Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt IV Administration Primary Set Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt IV Administration Primary Set Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt IV Administration Primary Set Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BD
  2. 8.1.1 BD Company Information
  3. 8.1.2 BD Business Overview
  4. 8.1.3 BD IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BD IV Administration Primary Set Product Portfolio
  6. 8.1.5 BD Recent Developments
  7. 8.2 SB Kawasumi
  8. 8.2.1 SB Kawasumi Company Information
  9. 8.2.2 SB Kawasumi Business Overview
  10. 8.2.3 SB Kawasumi IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 SB Kawasumi IV Administration Primary Set Product Portfolio
  12. 8.2.5 SB Kawasumi Recent Developments
  13. 8.3 Amsino
  14. 8.3.1 Amsino Company Information
  15. 8.3.2 Amsino Business Overview
  16. 8.3.3 Amsino IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Amsino IV Administration Primary Set Product Portfolio
  18. 8.3.5 Amsino Recent Developments
  19. 8.4 Bayer
  20. 8.4.1 Bayer Company Information
  21. 8.4.2 Bayer Business Overview
  22. 8.4.3 Bayer IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Bayer IV Administration Primary Set Product Portfolio
  24. 8.4.5 Bayer Recent Developments
  25. 8.5 Baxter International
  26. 8.5.1 Baxter International Company Information
  27. 8.5.2 Baxter International Business Overview
  28. 8.5.3 Baxter International IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Baxter International IV Administration Primary Set Product Portfolio
  30. 8.5.5 Baxter International Recent Developments
  31. 8.6 Zyno Medical
  32. 8.6.1 Zyno Medical Company Information
  33. 8.6.2 Zyno Medical Business Overview
  34. 8.6.3 Zyno Medical IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zyno Medical IV Administration Primary Set Product Portfolio
  36. 8.6.5 Zyno Medical Recent Developments
  37. 8.7 Smiths Medical
  38. 8.7.1 Smiths Medical Company Information
  39. 8.7.2 Smiths Medical Business Overview
  40. 8.7.3 Smiths Medical IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Smiths Medical IV Administration Primary Set Product Portfolio
  42. 8.7.5 Smiths Medical Recent Developments
  43. 8.8 MPS Medical
  44. 8.8.1 MPS Medical Company Information
  45. 8.8.2 MPS Medical Business Overview
  46. 8.8.3 MPS Medical IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 MPS Medical IV Administration Primary Set Product Portfolio
  48. 8.8.5 MPS Medical Recent Developments
  49. 8.9 Medtec Medical
  50. 8.9.1 Medtec Medical Company Information
  51. 8.9.2 Medtec Medical Business Overview
  52. 8.9.3 Medtec Medical IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Medtec Medical IV Administration Primary Set Product Portfolio
  54. 8.9.5 Medtec Medical Recent Developments
  55. 8.10 MedSource Labs
  56. 8.10.1 MedSource Labs Company Information
  57. 8.10.2 MedSource Labs Business Overview
  58. 8.10.3 MedSource Labs IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MedSource Labs IV Administration Primary Set Product Portfolio
  60. 8.10.5 MedSource Labs Recent Developments
  61. 8.11 ICU Medical
  62. 8.11.1 ICU Medical Company Information
  63. 8.11.2 ICU Medical Business Overview
  64. 8.11.3 ICU Medical IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 ICU Medical IV Administration Primary Set Product Portfolio
  66. 8.11.5 ICU Medical Recent Developments
  67. 8.12 Eitan Group
  68. 8.12.1 Eitan Group Company Information
  69. 8.12.2 Eitan Group Business Overview
  70. 8.12.3 Eitan Group IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Eitan Group IV Administration Primary Set Product Portfolio
  72. 8.12.5 Eitan Group Recent Developments
  73. 8.13 CODAN US Corporation
  74. 8.13.1 CODAN US Corporation Company Information
  75. 8.13.2 CODAN US Corporation Business Overview
  76. 8.13.3 CODAN US Corporation IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 CODAN US Corporation IV Administration Primary Set Product Portfolio
  78. 8.13.5 CODAN US Corporation Recent Developments
  79. 8.14 B. Braun
  80. 8.14.1 B. Braun Company Information
  81. 8.14.2 B. Braun Business Overview
  82. 8.14.3 B. Braun IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 B. Braun IV Administration Primary Set Product Portfolio
  84. 8.14.5 B. Braun Recent Developments
  85. 8.15 Advanced Medical Systems
  86. 8.15.1 Advanced Medical Systems Company Information
  87. 8.15.2 Advanced Medical Systems Business Overview
  88. 8.15.3 Advanced Medical Systems IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Advanced Medical Systems IV Administration Primary Set Product Portfolio
  90. 8.15.5 Advanced Medical Systems Recent Developments
  91. 8.16 3M
  92. 8.16.1 3M Company Information
  93. 8.16.2 3M Business Overview
  94. 8.16.3 3M IV Administration Primary Set Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 3M IV Administration Primary Set Product Portfolio
  96. 8.16.5 3M Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IV Administration Primary Set Value Chain Analysis
  2. 9.1.1 IV Administration Primary Set Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IV Administration Primary Set Sales Mode & Process
  6. 9.2 IV Administration Primary Set Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IV Administration Primary Set Distributors
  9. 9.2.3 IV Administration Primary Set Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst